Related Experiment Video

Updated: Dec 21, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.3K

Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement

Glenis K Scadding1, Peter W Hellings2,3,4, Claus Bachert3,5,6

  • 1Royal National TNE Hospital and Department of Immunology, University College London, United Kingdom.

The World Allergy Organization Journal
|May 20, 2020
PubMed

Insights

Optimal care for allergic rhinitis (AR) and asthma during COVID-19 is crucial. Recommendations address managing pollen allergy symptoms to prevent coronavirus spread, including guidance on allergen-specific immunotherapy (AIT).

Area of Science:

  • Allergy and Immunology
  • Infectious Diseases
  • Public Health

Background:

  • The 2020 spring and summer seasons presented unique challenges due to the overlap of pollen allergy season and the COVID-19 pandemic.
  • Managing allergic rhinitis (AR) and asthma is critical for preventing the spread of coronavirus through respiratory droplets from sneezing, rhinorrhea, and coughing.

Purpose of the Study:

  • To provide expert recommendations for the optimal care of patients with allergic airway diseases during the COVID-19 pandemic.
  • To address the similarities and differences between allergic rhinitis and coronavirus infection.
  • To offer guidance on allergen-specific immunotherapy (AIT) in the context of COVID-19.

Main Methods:

  • A review of current COVID-19 literature.
  • Analysis of keywords related to allergic airway diseases and COVID-19.
  • Consensus building based on shared clinical experience from EUFOREA expert teams.

Main Results:

  • Key considerations for managing AR and asthma during the pandemic are outlined.
  • Specific recommendations are provided for patient care, focusing on symptom control and infection prevention.
  • Guidance on the continuation or initiation of allergen-specific immunotherapy (AIT) is discussed.

Conclusions:

  • Integrated management of allergic airway diseases and COVID-19 is essential for patient well-being and public health.
  • Adherence to expert recommendations can help mitigate risks associated with both conditions.
  • Further research and clinical vigilance are necessary to refine care strategies.

Keywords:
AIT, allergen-specific immunotherapyAR, allergic rhinitisAllergen-specific immunotherapyAllergyAsthmaCOVID-19COVID-19, coronavirus disease 2019ControlEUFOREA, European Forum for Research and Education in Allergy and Airway DiseasesINS, intranasal corticosteroidsNSAID, non-steroidal anti-inflammatory drugRhinitisSAR, seasonal allergic rhinitisSmell and tasteSymptomsTreatment

More Related Videos

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.9K
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.0K

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
913
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.6K
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.2K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K